USD 23.0 billion
Report ID:
SQMIG35D2068 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
65
|Figures:
78
Clinical Trials Support Services Market size was valued at USD 23.0 billion in 2023 and is poised to grow from USD 24.84 billion in 2024 to USD 45.98 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).
Clinical testing, assay design, and support services for clinical trials are all very helpful. It also includes duties including securing and storing research medications, safeguarding clinical test sites, calculating drug dosages, and managing kits.
Clinical test support services, which include clinical test site help, obtaining and storing study drugs, blinding of study drugs, patient recruitment, coordination, and reconciliation of returned pharmaceuticals, provide the preclinical foundation and research. Significant changes were made to the clinical trial industry in 2021.
Numerous clinical trials that had been postponed owing to the pandemic were restarted with the development of COVID-19 vaccines. There are many unmet demands for the creation of novel pharmaceuticals for the treatment, which necessitates carrying out clinical trials. This is due to the increased prevalence of chronic, infectious, and tropical diseases in emerging nations.
One of the key elements that has contributed to the industry's clinical trials support services sector's revenue growth post-pandemic is the use of virtual clinical trials. In order to streamline their clinical research services, an increasing number of clinical research firms are putting their attention on the deployment of virtual technology.
US Clinical Trials Support Services Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 23.0 billion
Largest Segment
Fastest Growth
phase I
Growth Rate
8.0% CAGR
To get more reports on the above market click here to Buy The Report
Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The market is divided into four phases: phases I, II, III, and IV, with phases III accounting for the biggest market share. There are a number of reasons why Phase III trials are the most expensive and have the largest subject populations. This increases interest in the phase III segment.
The market is divided into Autoimmune/Inflammation, Oncology, Diabetes, Cardiovascular, and Others based on indication. The category for oncology is anticipated to have the highest CAGR during the projection period. The factors driving the pharmaceutical industry's substantial spending on the preclinical and clinical development of cancer therapeutic items are boosting demand for the oncology market.
To get detailed analysis on other segments, Request For Free Sample Report
On the basis of region, Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA).As the majority of the pharmaceutical companies in the United States do the majority of their business in this region, North America dominated the global market in 2021 with the greatest share of 50.4%. Due to the large number of clinical studies being undertaken in the area, this market is most likely to expand. Government funding for clinical trials and large R&D investments are furthering the market's expansion. The expansion of the market in North America has been attributed to the existence of significant CROs that provide clinical trial support services and multinational pharmaceutical and biopharmaceutical companies that make significant expenditures in clinical research. The fastest-growing geographical market over the projection period is expected to be Asia Pacific. The APAC market is driven by a growing patient population, easy administrative compliance, and low cost.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
High Investment to Develop Medical Infrastructure to Bolster Market Growth
Suspended R&D to Hinder Market Growth
Request Free Customization of this report to help us to meet your business objectives.
Market competition for clinical trials support services is average. The main methods used by players to establish and expand their presence in the clinical trial support services market include growing product launches, partnerships, collaborations, agreements, and market expansions. Alcura Health, Charles River Laboratories, Laboratory Corporation of America Holdings (Covance Inc.), Eurofins Scientific, ICON PLC, Parexel International, PPD Inc., and WuXi PharmaTech are some of the main companies in the market.
SkyQuest's ABIRAWA (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, The increased uptake of cutting-edge medical technologies and the expanding demand for novel pharmaceuticals are driving up demand for the clinical trials sector. Additionally, the high costs and substantially lower approval rates of the medication development process make it exceedingly dangerous for pharmaceutical and biotechnology companies, which restricts the market growth for clinical trials. As a result, contract research organisations (CROs) are increasingly being used to conduct clinical trials, which allows sponsors to focus primarily on the development of new drugs and improves the prognosis for the market. Increased prevalence of infectious and tropical diseases in the region, along with high unmet clinical trial demand in developing nations, are driving the market. The demand for research and development in pharmaceutical businesses to create novel molecules is growing as a result of multiple patent expirations.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 23.0 billion |
Market size value in 2032 | USD 45.98 billion |
Growth Rate | 8.0% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Clinical Trials Support Services Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Trials Support Services Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Trials Support Services Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Clinical Trials Support Services Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Clinical Trials Support Services Market size was valued at USD 22.42 Billion in 2023 and is poised to grow from USD 24.1 Billion in 2024 to USD 42.99 Billion by 2032, growing at a CAGR of 7.50% during the forecast period (2025-2032).
Market competition for clinical trials support services is average. The main methods used by players to establish and expand their presence in the clinical trial support services market include growing product launches, partnerships, collaborations, agreements, and market expansions. Alcura Health, Charles River Laboratories, Laboratory Corporation of America Holdings (Covance Inc.), Eurofins Scientific, ICON PLC, Parexel International, PPD Inc., and WuXi PharmaTech are some of the main companies in the market. 'IQVIA Holdings Inc.', 'PAREXEL International Corporation (a subsidiary of Pamplona Capital Management)', 'Charles River Laboratories International Inc.', 'PRA Health Sciences Inc.', 'ICON Plc', 'Syneos Health Inc.', 'Pharmaceutical Product Development LLC (PPD)', 'Wuxi AppTec Inc.', 'Medpace Holdings Inc.', 'SGS SA', 'Covance Inc. (a subsidiary of LabCorp)', 'Celerion Inc.', 'Clinipace Worldwide', 'Worldwide Clinical Trials Inc.', 'Novotech Pty Ltd.', 'MMS Holdings Inc.', 'Premier Research Group Ltd.', 'Medidata Solutions Inc. (a subsidiary of Dassault Systèmes)', 'Anavex Life Sciences Corp.', 'Cromsource Srl', 'Clincierge was acquired by Greenphire in February 2024, marking a major development in the market for clinical trial support services. By combining Clincierge's patient-focused travel and logistics support with Greenphire's digital solutions for accelerating clinical trials, this acquisition aims to enhance clinical trial support services. ', 'A strategic relationship between Lotus Clinical Research and Trialogics was formed in August 2023 with the goal of providing clinical trial software services. The purpose of this joint endeavor was to maximize clinical trial efficacy and efficiency by employing Trialogics' software platform. Through this partnership, Lotus Clinical Research will be able to improve customer services and optimize its operational procedures. ', 'Syneos Health and Microsoft signed a multiyear contract in March 2023 to develop a platform that leverages machine learning to improve the commercial performance of biopharma businesses and expedite the planning, analysis, and execution of clinical trials.'
The high burden of infectious and chronic diseases, the high research and development expenditures of pharmaceutical firms, the proliferation of contract research organisations, and the demand for clinical trials in growing countries are the main drivers of the market's growth.
The expanding need for trials in emerging nations, rising R&D investment, and a rise in the number of contract research organisations all point to a rapid expansion of the worldwide market (CROs). Every year, the pharmaceutical companies' (R&D) spending has been continuously rising, mostly as a result of patent expirations.
On the basis of region, Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA).As the majority of the pharmaceutical companies in the United States do the majority of their business in this region, North America dominated the global market in 2021 with the greatest share of 50.4%. Due to the large number of clinical studies being undertaken in the area, this market is most likely to expand. Government funding for clinical trials and large R&D investments are furthering the market's expansion. The expansion of the market in North America has been attributed to the existence of significant CROs that provide clinical trial support services and multinational pharmaceutical and biopharmaceutical companies that make significant expenditures in clinical research. The fastest-growing geographical market over the projection period is expected to be Asia Pacific. The APAC market is driven by a growing patient population, easy administrative compliance, and low cost.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35D2068
[email protected]
USA +1 351-333-4748